Global Immuno Oncology Assays Kit Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Immuno Oncology Assays Kit Market
Immuno-Oncology Assays Accelerate Cancer Immunotherapy enable fast, effective, and clinically relevant understanding of immuno-oncology targets, pathways and mechanisms, enabling quicker development of immuno-oncology drugs. Learn how you can rapidly screen and develop antibodies targeting checkpoint receptors, bi-specific antibodies, small molecules, or cellular therapies such as chimeric antigen receptor T-cells (CAR-T).

Due to the COVID-19 pandemic, the global Immuno Oncology Assays Kit market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Immunoassay accounting for % of the Immuno Oncology Assays Kit global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Research segment is altered to an % CAGR throughout this forecast period.

China Immuno Oncology Assays Kit market size is valued at US$ million in 2021, while the US and Europe Immuno Oncology Assays Kit are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Immuno Oncology Assays Kit landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Immuno Oncology Assays Kit include Thermo Fischer Scientific, Roche Diagnostics, Agilent Technologies and Illumina, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Market Segments

The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.

Segment by Type

Immunoassay

Flow Cytometry

PCR

Next Generation Sequencing

Segment by Application

Research

Clinical Diagnostics

Consequence of Covid-19 Pandemic

The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Immuno Oncology Assays Kit market back to the pre-covid levels.

Trends & Prospects

In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

Competitive Outlook

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

Thermo Fischer Scientific

Roche Diagnostics

Agilent Technologies

Illumina

TABLE OF CONTENT

1 Study Coverage
1.1 Immuno Oncology Assays Kit Product Introduction

1.2 Market by Type

1.2.1 Global Immuno Oncology Assays Kit Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Immunoassay

1.2.3 Flow Cytometry

1.2.4 PCR

1.2.5 Next Generation Sequencing

1.3 Market by Application

1.3.1 Global Immuno Oncology Assays Kit Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Research

1.3.3 Clinical Diagnostics

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Immuno Oncology Assays Kit Sales Estimates and Forecasts 2017-2028

2.2 Global Immuno Oncology Assays Kit Revenue Estimates and Forecasts 2017-2028

2.3 Global Immuno Oncology Assays Kit Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Immuno Oncology Assays Kit Sales by Region

2.4.1 Global Immuno Oncology Assays Kit Sales by Region (2017-2022)

2.4.2 Global Sales Immuno Oncology Assays Kit by Region (2023-2028)

2.5 Global Immuno Oncology Assays Kit Revenue by Region

2.5.1 Global Immuno Oncology Assays Kit Revenue by Region (2017-2022)

2.5.2 Global Immuno Oncology Assays Kit Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Immuno Oncology Assays Kit Sales by Manufacturers

3.1.1 Global Top Immuno Oncology Assays Kit Manufacturers by Sales (2017-2022)

3.1.2 Global Immuno Oncology Assays Kit Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Immuno Oncology Assays Kit in 2021

3.2 Global Immuno Oncology Assays Kit Revenue by Manufacturers

3.2.1 Global Immuno Oncology Assays Kit Revenue by Manufacturers (2017-2022)

3.2.2 Global Immuno Oncology Assays Kit Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Immuno Oncology Assays Kit Revenue in 2021

3.3 Global Immuno Oncology Assays Kit Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Immuno Oncology Assays Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Immuno Oncology Assays Kit Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Immuno Oncology Assays Kit Sales by Type

4.1.1 Global Immuno Oncology Assays Kit Historical Sales by Type (2017-2022)

4.1.2 Global Immuno Oncology Assays Kit Forecasted Sales by Type (2023-2028)

4.1.3 Global Immuno Oncology Assays Kit Sales Market Share by Type (2017-2028)

4.2 Global Immuno Oncology Assays Kit Revenue by Type

4.2.1 Global Immuno Oncology Assays Kit Historical Revenue by Type (2017-2022)

4.2.2 Global Immuno Oncology Assays Kit Forecasted Revenue by Type (2023-2028)

4.2.3 Global Immuno Oncology Assays Kit Revenue Market Share by Type (2017-2028)

4.3 Global Immuno Oncology Assays Kit Price by Type

4.3.1 Global Immuno Oncology Assays Kit Price by Type (2017-2022)

4.3.2 Global Immuno Oncology Assays Kit Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Immuno Oncology Assays Kit Sales by Application

5.1.1 Global Immuno Oncology Assays Kit Historical Sales by Application (2017-2022)

5.1.2 Global Immuno Oncology Assays Kit Forecasted Sales by Application (2023-2028)

5.1.3 Global Immuno Oncology Assays Kit Sales Market Share by Application (2017-2028)

5.2 Global Immuno Oncology Assays Kit Revenue by Application

5.2.1 Global Immuno Oncology Assays Kit Historical Revenue by Application (2017-2022)

5.2.2 Global Immuno Oncology Assays Kit Forecasted Revenue by Application (2023-2028)

5.2.3 Global Immuno Oncology Assays Kit Revenue Market Share by Application (2017-2028)

5.3 Global Immuno Oncology Assays Kit Price by Application

5.3.1 Global Immuno Oncology Assays Kit Price by Application (2017-2022)

5.3.2 Global Immuno Oncology Assays Kit Price Forecast by Application (2023-2028)

6 North America

6.1 North America Immuno Oncology Assays Kit Market Size by Type

6.1.1 North America Immuno Oncology Assays Kit Sales by Type (2017-2028)

6.1.2 North America Immuno Oncology Assays Kit Revenue by Type (2017-2028)

6.2 North America Immuno Oncology Assays Kit Market Size by Application

6.2.1 North America Immuno Oncology Assays Kit Sales by Application (2017-2028)

6.2.2 North America Immuno Oncology Assays Kit Revenue by Application (2017-2028)

6.3 North America Immuno Oncology Assays Kit Market Size by Country

6.3.1 North America Immuno Oncology Assays Kit Sales by Country (2017-2028)

6.3.2 North America Immuno Oncology Assays Kit Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Immuno Oncology Assays Kit Market Size by Type

7.1.1 Europe Immuno Oncology Assays Kit Sales by Type (2017-2028)

7.1.2 Europe Immuno Oncology Assays Kit Revenue by Type (2017-2028)

7.2 Europe Immuno Oncology Assays Kit Market Size by Application

7.2.1 Europe Immuno Oncology Assays Kit Sales by Application (2017-2028)

7.2.2 Europe Immuno Oncology Assays Kit Revenue by Application (2017-2028)

7.3 Europe Immuno Oncology Assays Kit Market Size by Country

7.3.1 Europe Immuno Oncology Assays Kit Sales by Country (2017-2028)

7.3.2 Europe Immuno Oncology Assays Kit Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Immuno Oncology Assays Kit Market Size by Type

8.1.1 Asia Pacific Immuno Oncology Assays Kit Sales by Type (2017-2028)

8.1.2 Asia Pacific Immuno Oncology Assays Kit Revenue by Type (2017-2028)

8.2 Asia Pacific Immuno Oncology Assays Kit Market Size by Application

8.2.1 Asia Pacific Immuno Oncology Assays Kit Sales by Application (2017-2028)

8.2.2 Asia Pacific Immuno Oncology Assays Kit Revenue by Application (2017-2028)

8.3 Asia Pacific Immuno Oncology Assays Kit Market Size by Region

8.3.1 Asia Pacific Immuno Oncology Assays Kit Sales by Region (2017-2028)

8.3.2 Asia Pacific Immuno Oncology Assays Kit Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

8.3.12 Philippines

9 Latin America

9.1 Latin America Immuno Oncology Assays Kit Market Size by Type

9.1.1 Latin America Immuno Oncology Assays Kit Sales by Type (2017-2028)

9.1.2 Latin America Immuno Oncology Assays Kit Revenue by Type (2017-2028)

9.2 Latin America Immuno Oncology Assays Kit Market Size by Application

9.2.1 Latin America Immuno Oncology Assays Kit Sales by Application (2017-2028)

9.2.2 Latin America Immuno Oncology Assays Kit Revenue by Application (2017-2028)

9.3 Latin America Immuno Oncology Assays Kit Market Size by Country

9.3.1 Latin America Immuno Oncology Assays Kit Sales by Country (2017-2028)

9.3.2 Latin America Immuno Oncology Assays Kit Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Immuno Oncology Assays Kit Market Size by Type

10.1.1 Middle East and Africa Immuno Oncology Assays Kit Sales by Type (2017-2028)

10.1.2 Middle East and Africa Immuno Oncology Assays Kit Revenue by Type (2017-2028)

10.2 Middle East and Africa Immuno Oncology Assays Kit Market Size by Application

10.2.1 Middle East and Africa Immuno Oncology Assays Kit Sales by Application (2017-2028)

10.2.2 Middle East and Africa Immuno Oncology Assays Kit Revenue by Application (2017-2028)

10.3 Middle East and Africa Immuno Oncology Assays Kit Market Size by Country

10.3.1 Middle East and Africa Immuno Oncology Assays Kit Sales by Country (2017-2028)

10.3.2 Middle East and Africa Immuno Oncology Assays Kit Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Thermo Fischer Scientific

11.1.1 Thermo Fischer Scientific Corporation Information

11.1.2 Thermo Fischer Scientific Overview

11.1.3 Thermo Fischer Scientific Immuno Oncology Assays Kit Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Thermo Fischer Scientific Immuno Oncology Assays Kit Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Thermo Fischer Scientific Recent Developments

11.2 Roche Diagnostics

11.2.1 Roche Diagnostics Corporation Information

11.2.2 Roche Diagnostics Overview

11.2.3 Roche Diagnostics Immuno Oncology Assays Kit Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Roche Diagnostics Immuno Oncology Assays Kit Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Roche Diagnostics Recent Developments

11.3 Agilent Technologies

11.3.1 Agilent Technologies Corporation Information

11.3.2 Agilent Technologies Overview

11.3.3 Agilent Technologies Immuno Oncology Assays Kit Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Agilent Technologies Immuno Oncology Assays Kit Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Agilent Technologies Recent Developments

11.4 Illumina

11.4.1 Illumina Corporation Information

11.4.2 Illumina Overview

11.4.3 Illumina Immuno Oncology Assays Kit Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Illumina Immuno Oncology Assays Kit Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Illumina Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Immuno Oncology Assays Kit Industry Chain Analysis

12.2 Immuno Oncology Assays Kit Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Immuno Oncology Assays Kit Production Mode & Process

12.4 Immuno Oncology Assays Kit Sales and Marketing

12.4.1 Immuno Oncology Assays Kit Sales Channels

12.4.2 Immuno Oncology Assays Kit Distributors

12.5 Immuno Oncology Assays Kit Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Immuno Oncology Assays Kit Industry Trends

13.2 Immuno Oncology Assays Kit Market Drivers

13.3 Immuno Oncology Assays Kit Market Challenges

13.4 Immuno Oncology Assays Kit Market Restraints

14 Key Findings in The Global Immuno Oncology Assays Kit Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

Delivery Format : EXCEL/Data Pack

Choose License Type

Checkout Inquiry Sample